Material Insights · Understanding the Material World

mRNA vaccines: Overview

What it does

The job the technology does for people, in a short paragraph

An mRNA vaccine trains the immune system by giving cells the instructions to make one harmless protein of a germ, instead of the germ itself. The first two were approved against COVID-19 in December 2020 [1]. More than 13 billion COVID-19 vaccine doses of all types, mRNA and others, had been given by 2023 [1].

as of 2026-11-11

How it works

The working principle in plain words, step by step

Cells use messenger RNA, a short-lived copy of a gene, as a template for making proteins [1]. An mRNA vaccine contains an mRNA that codes for one protein from the surface of a virus. The mRNA is made in a tank by enzymes copying a DNA template, without growing any cells [2]. Its building blocks are slightly changed so the body does not treat it as an invader and set off inflammation [1]. The mRNA is wrapped in tiny fat droplets, lipid nanoparticles, which protect it and carry it into cells [3]. After the injection, cells read the message, make the protein and show it to the immune system, which makes antibodies and memory cells. The mRNA itself is short-lived and soon breaks down.

as of 2026-11-11

Key figures

The handful of numbers that size it up, each with its unit, year and source

FigureValueUnitYearSource
COVID-19 vaccine doses given worldwide, all types (not only mRNA), more than13billion doses2023[1]
Pfizer's reported revenue from Comirnaty, its mRNA vaccine (direct sales and alliance revenues)37,806million USD2022[5]
Pfizer's reported total revenue100,330million USD2022[5]
Years from the key finding on modified mRNA to approval15years2020[1]

as of 2026-11-11. The dose count covers all COVID-19 vaccines, not only mRNA ones; it comes from the Nobel announcement of October 2023, so 2023 is the publication year, not a data year [1]. The revenue figures are Pfizer's own; about 38% of its 2022 revenue came from the vaccine (calculated: 37,806 / 100,330).

Where it is used

The main places and products the technology is found in

  • COVID-19 vaccines, approved from December 2020 [1]
  • National immunisation programmes and mass vaccination centres
  • Clinics and pharmacies giving booster doses
  • Research on vaccines against other infections and on cancer treatments [2]

as of 2026-11-11

Scale today

How much of it there is now: units in use, made each year and who uses it

Made per year
No count of mRNA doses alone was found; more than 13 billion COVID-19 doses of all types had been given by 2023 [1]
Unit
doses
Year
2023
Note
The count is for all COVID-19 vaccines, so it is an upper bound for mRNA vaccines; 2023 is the year of the Nobel announcement that gives it.

as of 2026-11-11

Sources

  1. Press release: The Nobel Prize in Physiology or Medicine 2023 The Nobel Assembly at Karolinska Institutet, 2023
  2. mRNA vaccines - a new era in vaccinology Nature Reviews Drug Discovery (N. Pardi, M. J. Hogan, F. W. Porter and D. Weissman), 2018
  3. The tangled history of mRNA vaccines Nature 597, 318 to 324 (Elie Dolgin), 2021
  4. Financial Performance (Pfizer 2022 Annual Review) Pfizer